Hayden is an associate editor for The American Journal of Managed Care® (AJMC®). She joined the AJMC team in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Ravi Parikh Offers Solutions to Barriers During Shift From Fee-for-Service to APMs
Designing rational spending targets and having small sample sizes are 2 main challenges payers and partners face in the shift toward alternative payment models (APMs), said Ravi B. Parikh, MD, MPP, assistant professor of medical ethics and health policy, assistant professor of medicine, University of Pennsylvania.
Dr Patricia Deverka Addresses Potential Disparities in Multicancer Early Detection Tests
Providing insurance coverage for multicancer early detection (MCED) tests is vital to reduce disparities in access, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.
Dr Michael Thorpy Explains Findings From REST-ON Trial for Narcolepsy Treatment
Once-nightly sodium oxybate was associated with a statistically significant reduction in cataplexy episodes among patients with narcolepsy, explained Michael Thorpy, MD, director of the Sleep-Wake Disorders Center at Montefiore Medical Center and professor of neurology at Albert Einstein College of Medicine.
Dr Sean Drummond Discusses Pros, Cons of Consumer Sleep Technology
While consumer wearables for sleep are popular, evidence-based guidelines need to be established to interpret data coming from these technologies, said Sean Drummond, PhD, professor of clinical neuroscience, Turner Institute for Brain and Mental Health at Monash University.
Rhinomed’s Michael Johnson Highlights 2022 Sleep and Snoring Report Findings
Michael Johnson, CEO of Rhinomed, expands on the findings of the 2022 Annual Global Sleep and Snoring Report conducted in February 2022, which found that people are not getting nearly as much sleep as they should.
Dr Stacey Simon Explains Effects of Type 1 Diabetes on Sleep
Behavioral and physiological components of type 1 diabetes and its management can contribute to worsened sleep and health outcomes, which can vary by age, according to Stacey Simon, PhD, sleep psychologist and associate professor, University of Colorado Denver, Children's Hospital Colorado.
Dr John Winkelman Emphasizes Importance of Long-term Research on Opioids for Restless Leg Syndrome
Opioids have been used for hundreds of years to treat restless leg syndrome (RLS), but there is currently a registry to understand the long-term effectiveness of opioids to treat RLS , said John Winkelman, MD, PhD, medical director, sleep disorders clinical research program, Massachusetts General Hospital.
Research Suggests COVID-19 Vaccines May Protect Against Pneumonia
Chest computed tomography scans demonstrated a lower frequency of pneumonia in fully vaccinated patients compared with unvaccinated patients, with a significantly lower frequency among patients who received the Pfizer vaccine.
Researchers Evaluate Whether Aquatic Exercise Is Most Effective Therapy for IA
Research supports that aquatic exercise is effective at reducing pain and disease activity and improving physical function, although it is unclear whether it is more effective than any other form of therapy for inflammatory arthritis (IA).
Dr Steven Yeh Discusses Future of Suprachoroidal Drug Delivery
Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, talks about what he sees in the future of suprachoroidal administration and other unmet needs in ophthalmology.
Dr John DeWitt Explains Findings on Achalasia Diagnosis, Treatment Trends
At Digestive Disease Week 2022, John M. DeWitt, MD, professor of medicine, Indiana University Health, explains his findings on the diagnosis and management of achalasia in 2022 and how the COVID-19 pandemic affected these trends.
Dr Sravanthi Parasa Emphasizes Importance of Clinical Education on AI
At Digestive Disease Week 2022, Sravanthi Parasa, MD, gastroenterologist at Swedish Gastroenterology, talks about how artificial intelligence (AI) is used in gastroenterology and what challenges it may pose for clinicians.
Dr Paul Feuerstadt Explains Findings of PUNCH CD2, CD3 Trials on RBX2660 for Recurrent C difficile
Investigational microbiota-based live therapeutic RBX2660 was found to be safe and effective at reducing Clostridioides difficile (C difficile) recurrence, said Paul Feuerstadt, MD, assistant clinical professor at Yale University School of Medicine, gastroenterologist at PACT Gastroenterology Center, at Digestive Disease Week 2022.
Dr Preethi Venkat Discusses Impact of Recurrent C difficile Hospitalizations in Patients With IBD
Outcomes were worse for patients hospitalized once for Clostridioides difficile infection compared with alternative reasons for hospitalization, but the risk of adverse outcomes did not seem to increase with recurrent admissions for C difficile, explained Preethi Venkat, MD, second-year internal medicine resident at University of California, San Diego, at Digestive Disease Week 2022.
Dr Eric Low Explains Challenges Surrounding Achalasia Diagnosis at DDW 2022
Because symptoms are similar to those of gastroesophageal reflux disease, achalasia is often misdiagnosed, explained Eric Low, MD, MPH, gastroenterology fellow at University of California, San Diego at Digestive Disease Week 2022.
Dr Fola May Describes Disparities in Colorectal Cancer Diagnosis, Treatment at DDW 2022
The accumulation of screening and treatment disparities are contributing to colorectal cancer incidence and mortality disparities, said Folasade (Fola) May, MD, PhD, gastroenterologist, health services researcher at University of California, Los Angeles, at Digestive Disease Week 2022.
High Proportions of Deaths Among Infants, Children Linked to RSV, Researchers Find
Researchers also found that 95% of respiratory syncytial virus (RSV)-associated acute lower respiratory infection episodes and more than 97% of RSV-attributable deaths were among children in low– and middle-income countries.
Dr Patricia Deverka on Determining Value of Multicancer Detection Tests
The value of multicancer early detection tests is based not only on cost, but cost in relation to the outcomes, said Patricia Deverka, MD, MS, senior researcher, deputy director at the Center for Translational and Policy Research and Precision Medicine, University of California San Francisco.
DREAMS HIV Interventions Linked to Favorable Behavioral Outcomes Among Young Women in South Africa
Adolescent girls and young women in South Africa were more likely to practice favorable sexual behaviors if they accessed DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe)–like interventions such as school-based HIV prevention and HIV testing.